We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ixico Plc (IXI) New Ord GBP0.01

Sell:6.75p Buy:7.25p 0 Change: No change
Market closed |  Prices as at close on 17 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.75p
Buy:7.25p
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.75p
Buy:7.25p
Change: No change
Market closed |  Prices as at close on 17 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Contact details

Address:
4th Fl, Griffin Court, 15 Long Lane
LONDON
EC1A 9PN
United Kingdom
Telephone:
+44 (020) 37637499
Website:
https://ixico.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 21 May 2024 21/05/24
Trading Announcement 13 March 2024 13/03/24
AGM 25 January 2024 25/01/24
Final results 05 December 2023 05/12/23
Trading Announcement 29 September 2023 29/09/23

General stock information

EPIC:
IXI
ISIN:
GB00BFXR4C20
Market cap:
£3.38 million
Shares in issue:
48.35 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Giulio Cerroni
    Chief Executive Officer, Executive Director
  • Grant Nash
    Chief Financial Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.